Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis

Company Overview

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

Key Stats

• Today's Range: C$0.10 to C$0.10
• 50-Day Range: C$0.10 to C$0.15
• 52-Week Range: C$0.09 to C$0.36
• Volume: 13,526 shs
• Average Volume: 73,105 shs
• Market Capitalization: C$17.05 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: CVE:VM
• CIK: N/A
• Web: www.voyageurminerals.ca
• Phone: 587-779-6166
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$1.66 million
• Net Margins: -10,796.29%
• Pretax Margin: N/A
• Return on Equity: -313.14%
• Return on Assets: -30.77%

Debt

• Debt-to-Equity Ratio: 6.05
• Current Ratio: 0.18
• Quick Ratio: 0.84

Sales & Book Value

• Annual Sales: C$30.96 thousand
• Price / Sales: 550.74
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 35.00
• Book Value: C$0.00 per share
• Price / Book: 25.68

Miscellaneous

• Outstanding Shares: 179,476,000
• Free Float: N/A
• Market Cap: C$17.05 million
• Optionable: Not Optionable
• Beta: 1.07